teva pharmaceuticals introduces the first generic glp-1 for weight loss brings to US market with Saxenda copycat approval Did you hear the huge

cities and digital channels in the coming months

Technology Platform: User-Friendly: Easy to navigate website/app Secure patient portal Clear instructions Works on mobile and desktop HIPAA-compliant security Issues: Confusing interface Frequent technical problems Poor mobile experience Security concerns No patient portal Questions to Ask Before Choosing: Essential Questions: Which providers will I see, and are they licensed in my state? What pharmacy will fill my prescription, and are they FDA-registered? Whats included in the monthly price? How often are follow-up appointments, and are they included? Can I choose between semaglutide and tirzepatide? What happens if I experience side effects? How do refills work? Whats your cancellation policy? Do you accept HSA/FSA? How quickly can I get started? If provider cant answer these clearly, thats a red flag

Sleep disruption affects some users during the peak side effect period

A phase 1 mechanistic study of people with T2D reported a mean weight change at week 28 of 11.2 kg among participants assigned to tirzepatide 15 mg as compared with 6.9 kg for semaglutide 1.0 mg and no change (0 kg) for placebo [38]

In its preclinical pitch deck, ASC35 outperformed once-weekly tirzepatide by about 71% in diet-induced obese mice and showed a half-life roughly six times longer than tirzepatide in non-human primates

For patients with severe or persistent GI symptoms, temporary dose reduction or holding the GLP-1 medication (under clinician guidance) may be considered